Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients (EDPARDSLDLTR)
Pediatric Acute Respiratory Distress Syndrome, Desflurane, Biliary Atresia
About this trial
This is an interventional treatment trial for Pediatric Acute Respiratory Distress Syndrome focused on measuring Pediatric Acute Respiratory Distress Syndrome, Living Donor Liver Transplant, Desflurane, Biliary atresia
Eligibility Criteria
Inclusion Criteria: The diagnosis was biliary atresia Living donors were either the father or the mother 3months ≤age ≤ 36 months Exclusion Criteria: The preoperative diagnosis was not biliary atresia The donor was not a parent Age <3months or>36 months The patient had perinatal disease or congenital cardiopulmonary deformity The patient had acute respiratory infection before surgery The patient had hepatopulmonary syndrome Retransplantation
Sites / Locations
- TianjinFCH
- TianjinFCH
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
propofol group
propofol and desflurane group
desflurane group